Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fluocinonide 0.05% ointment 30% in Emulsifying ointment
1304000P0AABKBK
|
Fluocinonide | Fluocinonide | Skin | No data available |
|
Fluocinonide 0.05% ointment 50% in White soft paraffin
1304000P0AABFBF
|
Fluocinonide | Fluocinonide | Skin | No data available |
|
Fluocortolone 0.25% / Fluocortolone hexanoate 0.25% ointment
1304000R0AABBBB
|
Fluocortolone | Fluocortolone | Skin | No data available |
|
Fluocortolone hexan 0.25%/Fluocortolone pival 0.25% crm
1304000R0AAABAB
|
Fluocortolone | Fluocortolone | Skin | No data available |
|
Flutrimazole 1% cream
1310020AAAAAAAA
|
Flutrimazole | Flutrimazole | Skin | No data available |
|
Formaldehyde 0.75% gel
1307000C0AAABAB
|
Formaldehyde (Topical) | Formaldehyde | Skin | No data available |
|
Formaldehyde 2% solution
1307000C0AAAHAH
|
Formaldehyde (Topical) | Formaldehyde | Skin | No data available |
|
Formaldehyde 5% solution
1307000C0AAADAD
|
Formaldehyde (Topical) | Formaldehyde | Skin | No data available |
|
Formaldehyde 6% solution
1307000C0AAAXAX
|
Formaldehyde (Topical) | Formaldehyde | Skin | No data available |
|
Framycetin gauze dressing 10cm x 10cm
1310011G0AAAEAE
|
Framycetin sulfate (Topical) | Framycetin sulfate | Skin | No data available |
|
Fucidin 2% gel
1310012F0BBABAC
|
Fucidin (Topical Cream/Gel) | Fusidic acid | Skin | No data available |
|
Full Marks 0.2% lotion
1310040S0BBABAB
|
Full Marks | Phenothrin | Skin | No data available |
|
Full Marks 0.5% liquid
1310040S0BBACAC
|
Full Marks | Phenothrin | Skin | No data available |
|
Full Marks 0.5% mousse
1310040S0BBADAD
|
Full Marks | Phenothrin | Skin | No data available |
|
Fumaderm 215mg gastro-resistant tablets
130502000BBCCA0
|
Proprietary compound preparation BNF 1305020 | Other psoriasis preparations | Skin | No data available |
|
Fumaderm Initial 105mg gastro-resistant tablets
130502000BBCDA0
|
Proprietary compound preparation BNF 1305020 | Other psoriasis preparations | Skin | No data available |
|
Fumaric acid 30mg tablets
1305020X0AAAAAA
|
Fumaric acid | Fumaric acid | Skin | No data available |
|
Fungederm 1% cream
1310020H0BGAAAB
|
Fungederm | Clotrimazole | Skin | No data available |
|
Fusidic acid 2% gel
1310012F0AAACAC
|
Fusidic acid (Topical) | Fusidic acid | Skin | No data available |
|
Galpharm Athletes Foot 1% cream
1310020H0BKABAB
|
Galpharm (Topical) | Clotrimazole | Skin | No data available |
|
Galpharm Cold Sore 5% cream
1310030C0BJAAAA
|
Galpharm (Aciclovir) | Aciclovir | Skin | No data available |
|
Galpharm Thrush Relief 1% cream
1310020H0BKAAAB
|
Galpharm (Topical) | Clotrimazole | Skin | No data available |
|
Galpharmmedical Antiseptic 0.5% cream
1310050D0BMAAAA
|
Galpharmmedical Antiseptic | Cetrimide | Skin | No data available |
|
Gam-O 80mg capsules
1305010I0BUABAB
|
Gam-O | Gamolenic acid | Skin | No data available |
|
Gamolenic acid 37mg / Vitamin E 10unit capsules
1305010I0AAAPAP
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.